These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33870649)

  • 1. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
    Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
    Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
    Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
    Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
    Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
    Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
    Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
    Front Immunol; 2021; 12():760683. PubMed ID: 34966384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion.
    Lv LL; Wang HB; Zhang YX; Zhai JW; Shen Y; Qu QX; Chen C
    BMC Immunol; 2023 Dec; 24(1):53. PubMed ID: 38087217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17/Treg imbalance in malignant pleural effusion.
    Yang WB; Ye ZJ; Xiang F; Zhang JC; Zhou Q
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):27-32. PubMed ID: 23392703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating T
    Yi FS; Zhang X; Zhai K; Huang ZY; Wu XZ; Wu MT; Shi XY; Pei XB; Dong SF; Wang W; Yang Y; Du J; Luo ZT; Shi HZ
    J Immunol; 2020 Nov; 205(10):2926-2935. PubMed ID: 33046503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
    Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
    Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
    Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
    Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
    Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
    Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
    Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated naïve B cells promote development of malignant pleural effusion by differential regulation of T
    Wu XZ; Shi XY; Zhai K; Yi FS; Wang Z; Wang W; Pei XB; Xu LL; Wang Z; Shi HZ
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L443-L455. PubMed ID: 29847991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
    Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
    Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper T cells in malignant pleural effusion.
    Yi FS; Zhai K; Shi HZ
    Cancer Lett; 2021 Mar; 500():21-28. PubMed ID: 33309856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
    Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
    Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
    Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
    Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion.
    Ye ZJ; Zhou Q; Gu YY; Qin SM; Ma WL; Xin JB; Tao XN; Shi HZ
    J Immunol; 2010 Nov; 185(10):6348-54. PubMed ID: 20952674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.
    Niu Y; Zhou Q
    Cell Mol Life Sci; 2022 Mar; 79(4):194. PubMed ID: 35298721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
    Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
    Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.